8 results found.

Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Mari Clinical Trial using Electrical impedance myography (EIM)

State University of New York - Upstate Medical University - Recruiting 35 years to 80 years.
- Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance.
Electrical impedance myography (EIM)

Ataxia, Motor Neuron Disease, Muscular Disease, Muscular Dystroph Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Clinical and Molecular Manifestations of Inherited Neurological Disorders.

Motor Neuron Disease Clinical Trial using A functional exercise program; A stretching exercise program

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 90 years.
- Effect of Functional Exercise in Patients With Spinal and Bulbar Muscular Atrophy.
A functional exercise program; A stretching exercise program

Neuromuscular Disease, Motor Neuron Disease, Inherited Neuromuscu Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Electrical Impedance Myography: Exploratory Studies in Normal Subjects and Patients With Neuromuscular Disorders.

Amyotrophic Lateral Sclerosis, Neurodegenerative Disease, or Moto Clinical Trial

Drexel University - Recruiting 18 years or older.
- ALS Tissue Donation Program.

Amyotrophic Lateral Sclerosis Clinical Trial

Carolinas Healthcare System - Recruiting 18 years or older.
- Establishment of a Tissue Bank (Blood, CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND)..

Motor Neuron Disease, or Amyotrophic Lateral Sclerosis (ALS) Clinical Trial using Cannabis Sativa extract Oromucosal spray

Ospedale San Raffaele - Recruiting 18 years to 80 years.
- A Fase II, Randomized, Double-Blind, Placebo-Controlled, Multicentre Study for the Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease Patients.
Cannabis Sativa extract Oromucosal spray

Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neuromuscula Clinical Trial using HYNR-CS-Allo

Hanyang University Seoul Hospital - Recruiting 25 years to 80 years.
- An Open-label, Phase 1 Trial for Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell('HYNR-CS-Allo Inj') Treatment in Amyotrophic Lateral Sclerosis(ALS).
HYNR-CS-Allo